Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-48P is a pseudogene related to the U4 small nuclear RNA family, annotated as a non-coding RNA. Unlike functional U4 small nuclear RNAs, which are integral to spliceosomal assembly and mRNA splicing, RNU4-48P does not produce a functional transcript and is not involved in cellular or pathological processes. Pseudogenes typically arise via duplication or retrotransposition and are genomically present but lack function due to accumulated mutations or absence of regulatory sequences[1]. Note: If you intended information about the functionally active U4 snRNA, refer to the gene RNU4-2, which encodes the U4 small nuclear RNA involved in mRNA splicing as part of the spliceosome[2][3][4][5]. In contrast, RNU4-48P (the queried entry) is not functional and should not be regarded as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 48, pseudogene (RNU4-48P).